ESP Webinar Series on Clinical TrialsPart II
23 October 202516:00 - 17:00 CEST
This webinar is part of a series:
Part II: 23 October 2025
More information will be communicated in due time.
Webinar Overview
- ESP will be organising a series of three webinars on clinical trials.
- All webinars will be offered free of charge.
- The webinars are recorded and will be made available to ESP members via the ESP educational platform.
Save the date for Part III:
Part III: 4 December 2025, 16:00 – 17:00 CET
Past webinars of this series:
Faculty
- Speaker: Dr Dellia Mezzanzanica, Head of Integrated Biology of Rare Tumors at Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
- Moderators:
- Prof. José Alejandro Pérez-Fidalgo, Department of Oncology and Hematology, INCLIVA Biomedical Research Institute, Hospital Clinico Universitario, Valencia, Spain
- Prof. Xavier Matias-Guiu, ESP President
- Prof. Catarina Eloy, Chair of the ESP Education Subcommittee
Webinar programme
- Introduction
- Relevance in the identification of new prognostic and predictive biomarkers
- Type of biomarkers
- Strategy for identifying a new biomarker in the context of a Clinical trial.
- Translational studies
- Sample management. Practical issues.
Registration
The webinar will be conducted via ZOOM.
Please click on the below button to register.
Certificate of attendance
- ESP members who participate in the live webinar will receive a personalised certificate of participation.
- The certificates will be disseminated after the completion of all three webinars of this series.
- To be eligible for a certificate it is not obligatory to attend all three webinars.
